A new ‘living drug’ that could represent one of the greatest successes in the fight against cancer is close to becoming widely available.
According to the Daily Mail T-cell immunotherapy involves the removal of white blood cells – the cells of the immune system – from the patient.
They are then manipulated and modified to allow them to recognise and attack cancer cells. The cells are then grown to high numbers in a lab before being put back into the patient.
Two landmark studies have now revealed the therapy’s stunning potential. One suggests it will last for at least 14 years in the body, raising the prospect of a permanent cure for cancer while the other saw 94 per cent of terminally ill patients completely free from cancer cells.
These results have been labelled as ‘extraordinary’ and ‘unprecedented in medicine’.
Researcher Dr Stanley Riddell said:
These are patients that have failed [every other treatment]. Most patients in our trial would be projected to have two to five months to live.
This is extraordinary… unprecedented in medicine to get response rates in this range in these very advanced patients.
We have a long way to go. The response is not always durable, some of these patients do relapse … but the early data is unprecedented.
Check out the video below detailing how it works.